Victor Appay, PhD, explains how long-term ART slows immune aging, boosting HIV viral suppression and paving the way for ...
In 2006, Gilead Sciences and Bristol Myers Squibb left a permanent mark on the HIV treatment paradigm by fusing together three antiretrovirals and creating the ...
"You know, an anti-science attitude together with an anti-vaccine attitude is not very good for the public health of the country or the world," Fauci said.
Grinspoon noted that even incremental reductions in blood pressure incidence can translate into meaningful declines in ...
Take this interview with you! Download this Interview as an MP3 and load it onto your iPod or other portable audio player. Medscape: Now to move our discussion to rather more specific resistance ...
John Weiser, a doctor and researcher, has treated people with HIV since the beginning of the AIDS epidemic in the 1980s. He joined the CDC’s HIV prevention team in 2011 to help lead its Medical ...
Matthew Herper covers medical innovation — both its promise and its perils. On Wednesday, the Food and Drug Administration approved a new medicine, lenacapavir (brand name: Yeztugo) that could be the ...
A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability that could lead to new therapies and bring the world closer to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results